AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dixon, J. M. S.
Right arrow Articles by Lipinski, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dixon, J. M. S.
Right arrow Articles by Lipinski, A. E.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1972 April; 1(4): 333-339
Copyright © 1972 American Society for Microbiology. All Rights Reserved.

Resistance of Group A Beta-Hemolytic Streptococci to Lincomycin and Erythromycin1

J. M. S. Dixon and A. E. Lipinski

a Provincial Laboratory of Public Health, The University of Alberta, Edmonton, Alberta, Canada

ABSTRACT

Ten (0.05%) of 18,628 strains of Streptococcus pyogenes isolated from clinical specimens in the 3 years 1968 to 1970 were resistant to lincomycin and erythromycin. All 10 strains were highly resistant to lincomycin, having minimal inhibitory concentration (MIC) values of 200 µg/ml. There were two degrees of resistance to erythromycin: four strains were highly resistant, having MIC values of 200 µg or more/ml; and six strains showed slight resistance, MIC values being 0.78 to 1.56 µg/ml. There was no known epidemiological relationship between any of the patients infected with the resistant strains, which belonged to a variety of T serotypes. A zonal pattern of resistance to lincomycin occurred in four strains, all of which were only slightly resistant to erythromycin. After incubation for 24 hr in a twofold dilution series of lincomycin in broth, the strains grew in 0.05 µg or less/ml and in 50 and 100 µg/ml, but not in intermediate concentrations. Tests in agar indicated that the bacterial population of one strain, but not of the other three, was homogeneous in respect to its ability to grow readily in low and high, but not in intermediate, concentrations. The zone phenomenon is of significance in the clinical laboratory, since unawareness of it might result in a highly resistant strain being regarded as susceptible to lincomycin in tube or plate MIC tests that do not include sufficiently high concentrations of lincomycin.


FOOTNOTES

1 Presented in part at the 11th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlantic City, N.J., October 1971.


Antimicrob Agents Chemother. 1972 April; 1(4): 333-339
Copyright © 1972 American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1972 by the American Society for Microbiology. All rights reserved.